These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7465616)

  • 1. [Biorhythms of bioavailability ("chronogalenics")].
    Hüttenrauch R
    Pharmazie; 1980; 35(11):709-11. PubMed ID: 7465616
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistical analysis of thermal biorhythms.
    De Prins J; Malbecq W
    Prog Clin Biol Res; 1982; 107():123-32. PubMed ID: 7167473
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of geomagnetic disturbance on human biorhythms].
    Chernukh AM; Vinogradova LI; Gekht BM; Novikova KF
    Probl Kosm Biol; 1982; 43():47-50. PubMed ID: 7100157
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioavailability and bioequivalence: average, population and/or individual.
    Colburn WA; Keefe DL
    J Clin Pharmacol; 2000 Jun; 40(6):559-60. PubMed ID: 10868304
    [No Abstract]   [Full Text] [Related]  

  • 5. Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies.
    Hellriegel ET; Bjornsson TD; Hauck WW
    Clin Pharmacol Ther; 1996 Dec; 60(6):601-7. PubMed ID: 8988062
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bioavailability of medications].
    Farré M; Roset PN; Mas M; Mas A
    Med Clin (Barc); 1998 Apr; 110(14):558. PubMed ID: 9646275
    [No Abstract]   [Full Text] [Related]  

  • 7. Contributions to medicine from bioavailability studies.
    Sharoky M
    Md Med J; 1987 Jul; 36(7):585-8. PubMed ID: 2888000
    [No Abstract]   [Full Text] [Related]  

  • 8. The bioavailability of drugs.
    Mishra B; Bhattacharya SK
    Natl Med J India; 1993; 6(2):85-8. PubMed ID: 8477218
    [No Abstract]   [Full Text] [Related]  

  • 9. The potential clinical significance of differences in bioavailability.
    Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
    [No Abstract]   [Full Text] [Related]  

  • 10. Comments on the note for guidance on bioavailability and bioequivalence in the European Union.
    Calvo G
    Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():11. PubMed ID: 9800721
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative bioavailability of Mazetol and Tegretol.
    Batham AK
    J Assoc Physicians India; 1989 Jun; 37(6):413-4. PubMed ID: 2592338
    [No Abstract]   [Full Text] [Related]  

  • 12. [Generic drugs, bioavailability, and bioequivalence].
    Palma-Aguirre JA
    Gac Med Mex; 1998; 134(4):491-4. PubMed ID: 9789395
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of bioavailability of two brands of rifampicin.
    Bhatt AD; Revankar SN
    J Assoc Physicians India; 1999 Jul; 47(7):752. PubMed ID: 10778615
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioavailability and bioequivalence requirements: abbreviated applications. Final Rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Dec; 67(244):77668-75. PubMed ID: 12492102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioavailability of two brands of carbamazepine. Reply from the authors.
    Bhatt AD
    J Assoc Physicians India; 1989 Sep; 37(9):619-20. PubMed ID: 2698888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differences in the bioavailability of delayed action and standard preparations of calcium antagonists].
    Blume H
    Internist (Berl); 1994 Aug; 35(8):782-3. PubMed ID: 7960558
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the bioavailability of MST Continus tablets and Oramorph SR tablets.
    Miller AJ; Smith KJ
    Palliat Med; 1996 Oct; 10(4):349-50. PubMed ID: 8931080
    [No Abstract]   [Full Text] [Related]  

  • 18. Interchangeability of oral contraceptive products. Expert Advisory Committee on Bioavailability, Health Protection Branch, Department of National Health and Welfare.
    CMAJ; 1991 May; 144(10):1223-4. PubMed ID: 2025817
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of compounding on bioavailability.
    Riviere JE
    J Am Vet Med Assoc; 1994 Jul; 205(2):226-31. PubMed ID: 7928583
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-equivalence of bioavailability between generic and branded form of sodium valproate.
    Dhanaraj M; Jayavelu A
    Neurol India; 2004 Sep; 52(3):398. PubMed ID: 15472447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.